Outlook Therapeutics' Lytenava has become the first ophthalmic formulation of VEGF ... price – at £470 for one vial of 7.5 mg per 0.3 ml solution – is "similar to the cost of aflibercept." ...

Ophthalmic nonsteroidal anti-inflammatory agents ... Combination corticosteroid-antibiotic preparations, such as TobraDex ® (tobramycin 0.3%/dexamethasone 0.1%) (Alcon, Ft. Worth, TX), and ...